Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Scott Hecox

Hand Surgery Waco, TX Medical Doctor

NPI 1902184302 CMS profile 40396

140 Hillcrest Medical Blvd, Waco, TX 76712

Open in the dashboard

General payments

$70,084

141 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Scott Hecox of Waco, TX is reported in the CMS Open Payments database as having received $70,084 across 141 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $222 3
2024 General $198 2
2023 General $85 2
2022 General $1,246 3
2021 General $30,378 43
2020 General $1,936 18
2019 General $36,019 70

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Scott Hecox
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to Scott Hecox were reported at $222. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year Scott Hecox Hand Surgery median Middle half National median
2019 $36,019 $383 $106–$1,905 $163
2020 $1,936 $172 $51–$1,268 $114
2021 $30,378 $263 $71–$1,591 $132
2022 $1,246 $336 $87–$1,938 $149
2023 $85 $233 $81–$1,114 $160
2024 $198 $258 $88–$1,203 $164
2025 $222 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $64,944 118 payments
  2. Pylant Medical $4,966 21 payments
  3. TriMed, Inc. $144 1 payment
  4. Alnylam Pharmaceuticals Inc. $30 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $41,625 12 payments
  2. Consulting Fee $14,700 10 payments
  3. Travel and Lodging $7,142 47 payments
  4. Education $4,420 4 payments
  5. Food and Beverage $2,198 68 payments
Products named General payments · program years 2019–2025
  1. CAPITAL CONSUMABLES CONSUMABLES RF BRF $300 1 payment
  2. Tools - WFS $144 1 payment
  3. DISTAL EXTREMITIES IMPLANTS FRACTURE MANAGEMENT DISTAL RADIUS $39 1 payment
  4. ONPATTRO $30 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

387

Median for Orthopedic Surgery: 203

Drug cost

$2,100

Median for Orthopedic Surgery: $1,433

Branded share of claims

50.6%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 109 $906
Acetaminophen-Codeine Acetaminophen With Codeine Brand 64 $529
Ondansetron Hcl Generic 145 $418
Meloxicam Generic 46 $127
Tramadol Hcl-Acetaminophen Tramadol Hcl/Acetaminophen Brand 23 $120

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 88 billing codes

Paid by Medicare

$193,539

Of which drugs: $1,138

Medicare patients

411

Average age 73

Services billed

9,117

236 women, 175 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 71%
Arthritis 67%
Diabetes 29%
Ischemic heart disease 25%
Depression 25%
Osteoporosis 15%
Heart failure 14%
Chronic kidney disease 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 166 7,080 $706
Injection, methylprednisolone acetate, 20 mg J1020 Office 62 64 $320
Injection, methylprednisolone acetate, 40 mg J1030 Office 20 26 $109

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

141 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hand Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record